Graham Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-35,457
| Closed | -$545K | – | 1581 |
|
|
2025
Q1 | $545K | Sell |
35,457
-40,775
| -53% | -$627K | 0.01% | 739 |
|
|
2024
Q4 | $1.68M | Buy |
76,232
+45,542
| +148% | +$1M | 0.03% | 324 |
|
|
2024
Q3 | $553K | Sell |
30,690
-6,241
| -17% | -$112K | 0.01% | 581 |
|
|
2024
Q2 | $600K | Sell |
36,931
-108,899
| -75% | -$1.77M | 0.01% | 504 |
|
|
2024
Q1 | $2.06M | Buy |
145,830
+7,562
| +5% | +$107K | 0.04% | 226 |
|
|
2023
Q4 | $1.44M | Buy |
+138,268
| New | +$1.44M | 0.03% | 259 |
|
|
2015
Q1 | – | Sell |
-60,000
| Closed | -$3.45M | – | 125 |
|
|
2014
Q4 | $3.45M | Buy |
60,000
+25,000
| +71% | +$1.44M | 0.15% | 54 |
|
|
2014
Q3 | $1.88M | Buy |
35,000
+30,800
| +733% | +$1.66M | 0.08% | 70 |
|
|
2014
Q2 | $220K | Hold |
4,200
| – | – | 0.01% | 105 |
|
|
2014
Q1 | $222K | Buy |
+4,200
| New | +$222K | 0.01% | 82 |
|